China's Health Regulator Defends Quality of Local Generic Drugs

SHANGHAI (Reuters) – China’s healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed through the country’s public hospitals, saying an investigation into quality concerns had found them to be unsubstantiated. In an interview with the …